Stocks · Technology · Laboratory Analytical Instruments

HARVARD BIOSCIENCE INC

HBIO Clue Score31
United States Fiscal year ends December CIK 0001123494 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
James W Green
21 May 2021
Chief Executive Officer
Sold after exercise
24,312
$7.14
$173.59K
James W Green
20 May 2021
Chief Executive Officer
Sold after exercise
14,876
$7.03
$104.58K
James W Green
19 May 2021
Chief Executive Officer
Sold after exercise
39,188
$7.17
$280.98K
James W Green
18 May 2021
Chief Executive Officer
Sold after exercise
39,188
$7.41
$290.38K
Jeffrey Duchemin
9 Aug 2018
Chief Executive Officer
Sold after exercise
44,500
$6.41
$285.25K
Jeffrey Duchemin
8 Aug 2018
Chief Executive Officer
Sold after exercise
5,500
$6.35
$34.93K
Robert E. Gagnon
7 Aug 2018
Chief Financial Officer
Sold after exercise
100,015
$6.08
$608.09K
Jeffrey Duchemin
7 Aug 2018
Chief Executive Officer
Sold after exercise
100,000
$6.07
$607.00K
Robert E. Gagnon
27 Jul 2018
Chief Financial Officer
Sold after exercise
62,514
$5.54
$346.33K
Robert E. Gagnon
12 Jul 2018
Chief Financial Officer
Sold after exercise
9,145
$5.25
$48.01K
Robert E. Gagnon
11 Jul 2018
Chief Financial Officer
Sold after exercise
141,300
$5.23
$739.00K
Robert E. Gagnon
10 Jul 2018
Chief Financial Officer
Sold after exercise
13,700
$5.38
$73.71K
Robert E. Gagnon
9 Jul 2018
Chief Financial Officer
Sold after exercise
14,200
$5.41
$76.82K

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 13
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 12,898,770
Sales filed before the plan box existed 22
History held since 4 Oct 2006